Cost-effectiveness analysis of colorectal cancer treatments

被引:24
|
作者
van den Hout, WB
van den Brink, M
Stiggelbout, AM
van de Velde, CJH
Kievit, J
机构
[1] Leiden Univ, Med Ctr, Dept Med Decis Making, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Surg Oncol, NL-2300 RC Leiden, Netherlands
关键词
cost-effectiveness analysis; methodology; survey; colorectal cancer;
D O I
10.1016/S0959-8049(02)00053-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A concise overview is provided of the methodology of cost-effectiveness analyses, followed by a survey of published CEAs of colorectal cancer treatments. To gain credibility, the methodology applied in CEAs must be further improved. Costs are rarely estimated from the societal perspective, and little is known about how colorectal patients value their treatment and health. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:953 / 963
页数:11
相关论文
共 50 条
  • [1] Cost-effectiveness analysis of later-line treatments for refractory metastatic colorectal cancer
    Cho, Sang
    Bekaii-Saab, Tanios S.
    Hocum, Brian Thomas
    Grossman, Jamie
    Appukkuttan, Sreevalsa
    Babajanyan, Svetlana
    Yang, Min
    Lee, Woojung
    Barzi, Afsaneh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [2] COST-EFFECTIVENESS ANALYSIS OF CANCER TREATMENTS IN SOUTH OF IRAN
    Kiadaliri, Ahmad A.
    Bastani, P.
    Hatam, N.
    Ahmadloo, N.
    VALUE IN HEALTH, 2010, 13 (07) : A267 - A268
  • [3] Chemoprevention of colorectal cancer by aspirin: A cost-effectiveness analysis
    Suleiman, S
    Rex, DK
    Sonnenberg, A
    GASTROENTEROLOGY, 2002, 122 (01) : 78 - 84
  • [4] Cost-effectiveness analysis of regorafenib for metastatic colorectal cancer
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer
    Goldstein, Daniel A.
    Ahmad, Bilal B.
    Chen, Qiushi
    Ayer, Turgay
    Howard, David H.
    Lipscomb, Joseph
    El-Rayes, Bassel F.
    Flowers, Christopher R.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (32) : 3727 - +
  • [6] Cost-effectiveness analysis of adjuvant treatments in the management of breast cancer
    Selke, B
    Lenne, X
    Bercez, C
    Bonneterre, ME
    Lebrun, T
    Bonneterre, J
    MEDICAL DECISION MAKING, 1998, 18 (04) : 488 - 488
  • [7] Difficult decisions in the cost-effectiveness analysis of new cancer treatments
    Willemse, Pax H. B.
    Tjan-Heijnen, Vivianne C. G.
    EJHP PRACTICE, 2009, 15 (04): : 50 - 53
  • [8] Cost-effectiveness of screening for colorectal cancer
    Budenholzer, B
    Welch, HG
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (03) : 219 - 219
  • [9] Cost-effectiveness of Colorectal Cancer Screening
    Lansdorp-Vogelaar, Iris
    Knudsen, Amy B.
    Brenner, Hermann
    EPIDEMIOLOGIC REVIEWS, 2011, 33 (01) : 88 - 100
  • [10] Cost-effectiveness of colorectal cancer screening
    Heresbach, D
    Manfrédi, S
    Branger, B
    Bretagne, JF
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 (01): : 44 - 58